JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villalta, D
Right arrow Articles by Bagnasco, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villalta, D
Right arrow Articles by Bagnasco, M
Journal of Clinical Pathology 2004;57:378-382
© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists


ORIGINAL ARTICLE

Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers

D Villalta1, E Orunesu2, R Tozzoli3, P Montagna2, G Pesce2, N Bizzaro4, M Bagnasco2

1 Clinical Immunology and Virology Unit, City Hospital Pordenone, Via Montereale 24, 33170 Pordenone, Italy
2 Autoimmunity Laboratory, Medical and Radiometabolic Therapy Unit, DI.M.I. University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy
3 Clinical Pathology Unit, City Hospital Latisana, Via Sabbionera 45, 33053 Latisana, Italy
4 Clinical Pathology Unit, City Hospital San Donà di Piave, Via N. Sauro 25, 30027 San Donà di Piave, Italy

Correspondence to:
Dr M Bagnasco
Autoimmunity Laboratory, Medical and Radiometabolic Therapy Unit, DI.M.I. University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy; allerlab{at}unige.it Aims: To investigate the analytical and diagnostic accuracy of thyrotrophin (TSH) receptor antibody assays using recombinant human TSH receptors.

Methods: Sera from 68 patients with Graves’ disease, 23 patients with autoimmune thyroiditis, and 119 healthy controls were evaluated in four different laboratories using both radioactive and chemiluminescent tracers. Functional sensitivity, interlaboratory precision, optimal cutoff values for Graves’ disease, and the correlation between the two methods were evaluated.

Results: Functional sensitivity was 0.98 IU/litre for both assays. Interlaboratory precision, expressed as per cent coefficient of variation over a wide range of antibody concentrations, varied from 5.7% to 15.1% for the radioligand, and from 6.6% to 19.9% for the chemiluminescence assay. The two methods (radioactive and chemiluminescent) were closely correlated. All the sera from untreated or relapsing patients with Graves’ disease gave TSH receptor antibody values above 2.1 IU/litre, whereas in none of the healthy controls did values exceed 2.5 IU/litre. Receiver operating curve analysis allowed an optimal cutoff point to be defined at 1.99 IU/litre, according to a sensitivity of 100% and specificity of 99.1%.

Conclusions: These data show the high analytical and diagnostic accuracy of the human TSH receptor assays, both with radioactive and chemiluminescent tracers, when both functional sensitivity and interlaboratory reproducibility are considered. These two methods could be proposed as first line diagnostic markers for Graves’ disease.


Abbreviations: CI, confidence interval; CV, coefficient of variation; GD, Graves’ disease; TBII, thyrotrophin binding inhibitory immunoglobulins; TRAb, autoantibodies to the thyrotrophin receptor; TSH, thyrotrophin




This article has been cited by other articles:


Home page
Clin. Chem.Home page
E. Jensen, P. H. Petersen, O. Blaabjerg, P. S. Hansen, and L. Hegedus
Improved Sensitivity of a Thyrotropin Receptor Antibody Assay
Clin. Chem., November 1, 2005; 51(11): 2186 - 2187.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.